Total hip arthroplasty leads to the best outcomes in the treatment of moderate-to-severe hip osteoarthritis, according to a ...

Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...

Findings come amid growing off-label prescribing of GLP-1 drugs for addiction ...

A postbiotic reduced allergic rhinitis symptoms in a clinical trial. Could microbiome therapies transform treatment? Read ...

SQ Innovation today announced that results of the SUBCUT HF II trial of its product Lasix® ONYU, will be presented at Heart Failure 2026, the annual congress of the Heart Failure Association (HFA) of ...

Review authors suggested guidelines to help in standardizing future lupus nephritis studies. Heterogeneity in lupus nephritis (LN) trial design substantially hinders interpretation of studied drugs’ ...

Insulet anticipates a 510(k) submission for its fully closed-loop AID system in 2027 and market launch in 2028.

Background Patients undergoing thoracoscopic pulmonary resection are prone to moderate-to-severe acute postoperative pain, ...

While Africa accounts for roughly 25% of the global disease burden, its people are largely invisible in randomised controlled ...

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...

Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...